Lanreotide therapy vs active surveillance in MEN1-related pancreatic neuroendocrine tumors< 2 centimeters
A Faggiano, R Modica, F Lo Calzo… - The Journal of …, 2020 - academic.oup.com
Purpose Pancreatic neuroendocrine tumors (pNETs) are frequent in multiple endocrine
neoplasia type 1 (MEN1) syndrome. They are usually not surgically treated unless larger …
neoplasia type 1 (MEN1) syndrome. They are usually not surgically treated unless larger …
Lanreotide Therapy vs Active Surveillance in MEN1-Related Pancreatic Neuroendocrine Tumors< 2 Centimeters
A Faggiano, R Modica, F Lo Calzo… - THE JOURNAL OF …, 2020 - iris.unicampania.it
Purpose: Pancreatic neuroendocrine tumors (pNETs) are frequent in multiple endocrine
neoplasia type 1 (MEN1) syndrome. They are usually not surgically treated unless larger …
neoplasia type 1 (MEN1) syndrome. They are usually not surgically treated unless larger …
Lanreotide Therapy vs Active Surveillance in MEN1-Related Pancreatic Neuroendocrine Tumors< 2 Centimeters
A Faggiano, R Modica, F Lo Calzo, L Camera… - THE JOURNAL OF …, 2019 - iris.unipa.it
Purpose: Pancreatic neuroendocrine tumors (pNETs) are frequent in multiple endocrine
neoplasia type 1 (MEN1) syndrome. They are usually not surgically treated unless larger …
neoplasia type 1 (MEN1) syndrome. They are usually not surgically treated unless larger …
Lanreotide Therapy vs Active Surveillance in MEN1-Related Pancreatic Neuroendocrine Tumors< 2 Centimeters
A Faggiano, R Modica, F Lo Calzo… - The Journal of …, 2020 - academic.oup.com
Purpose Pancreatic neuroendocrine tumors (pNETs) are frequent in multiple endocrine
neoplasia type 1 (MEN1) syndrome. They are usually not surgically treated unless larger …
neoplasia type 1 (MEN1) syndrome. They are usually not surgically treated unless larger …
Lanreotide therapy vs active surveillance in MEN1-related pancreatic neuroendocrine tumors< 2 cm
A Faggiano, R Modica, F Lo Calzo, L Camera… - THE JOURNAL OF …, 2020 - iris.unina.it
Pancreatic neuroendocrine tumors (pNETs) are frequent in multiple endocrine neoplasia
type 1 (MEN1) syndrome. They are usually not surgically treated unless larger than 1 to 2 cm …
type 1 (MEN1) syndrome. They are usually not surgically treated unless larger than 1 to 2 cm …
Lanreotide Therapy vs Active Surveillance in MEN1-Related Pancreatic Neuroendocrine Tumors< 2 Centimeters
A Faggiano, R Modica, FL Calzo… - The Journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Purpose Pancreatic neuroendocrine tumors (pNETs) are frequent in multiple endocrine
neoplasia type 1 (MEN1) syndrome. They are usually not surgically treated unless larger …
neoplasia type 1 (MEN1) syndrome. They are usually not surgically treated unless larger …
Lanreotide Therapy vs Active Surveillance in MEN1-Related Pancreatic Neuroendocrine Tumors< 2 Centimeters.
A Faggiano, R Modica, L Camera… - The Journal of …, 2020 - europepmc.org
Pancreatic neuroendocrine tumors (pNETs) are frequent in multiple endocrine neoplasia
type 1 (MEN1) syndrome. They are usually not surgically treated unless larger than 1 to 2 cm …
type 1 (MEN1) syndrome. They are usually not surgically treated unless larger than 1 to 2 cm …
Lanreotide therapy vs active surveillance in MEN1-related pancreatic neuroendocrine tumors< 2 centimeters
A Faggiano, R Modica, F Lo Calzo… - THE JOURNAL OF …, 2019 - iris.uniroma1.it
Purpose: Pancreatic neuroendocrine tumors (pNETs) are frequent in multiple endocrine
neoplasia type 1 (MEN1) syndrome. They are usually not surgically treated unless larger …
neoplasia type 1 (MEN1) syndrome. They are usually not surgically treated unless larger …